Program

Day 1

8:00 AM – Registration

Session 1 – Tuesday 30 August 2011

Welcome – Co-Chairs, Mr David Learmonth and Mr Will Delaat

9:00 AM WELCOME TO COUNTRY
Mrs Agnes O’Shea OAM, Ngunnawal Community Elder
9:05 AM WELCOME TO THE CONFERENCE
Mr David Learmonth, Deputy Secretary, Department of Health and Ageing Mr Will Delaat, Chairman, Medicines Australia
9:10 AM OPENING ADDRESS
The Hon Nicola Roxon MP, Minister for Health and Ageing
9:25 AM OUTCOMES OF THE 2008 CONFERENCE AND WORK OF THE ACCESS TO MEDICINES WORKING GROUP
Mr David Learmonth, Deputy Secretary, Department of Health and Ageing Mr Will Delaat, Chairman, Medicines Australia
9:40 AM SETTING THE SCENE
9:40 AM Prof Lloyd Sansom AO, Emeritus Professor, Division of Health and Sciences, UniSA
9:45 AM Ms Carol Bennett, Chief Executive Officer, Consumers Health Forum
9:50 AM KEYNOTE ADDRESS
COMPARATIVE EFFECTIVENESS RESEARCH IN THE USA: PROGRESS AND CHALLENGES
Dr Sean R. Tunis, Founder and Director of Center for Medical Technology Policy, Baltimore, Maryland
10:30 AM MORNING TEA

Session 2

Future challenges to health technology assessment

Chair, Dr Sean Tunis Founder and Director of Center for Medical Technology Policy, Baltimore, Maryland

11:00 AM DATA REQUIREMENTS FOR THE FUTURE : HIGH COST/HIGHLY TARGETED THERAPIES
Prof Kathryn A. Phillips, Professor of Health Economics and Health Services Research, University of California, San Francisco
11:30 AM POLICY CHALLENGES
Prof Robyn Ward, Clinical Associate Dean, Prince of Wales Clinical School, University of NSW
12:00 PM ETHICS IN DRUG DEVELOPMENT PROCESS: SOCIETAL PERSPECTIVES
Ms Jennifer Doggett, Fellow, Centre for Policy Development
12:30 PM Q&A PANEL DISCUSSION
1:00 PM LUNCH

Session 3

Data linkages and consumer engagement

Chair, Mr Laurie Wilson President, National Press Club

2:00 PM USING LINKED DATA SETS TO IMPROVE HEALTHCARE DELIVERY
Assoc Prof Libby Roughead, Future Fellow, School of Pharmacy and Medical Science, University of South Australia
2:30 PM SENSITIVE HEALTH INFORMATION AND PRIVACY
Mr Malcolm Crompton, Managing Director, Information Integrity Solutions P/L
2:45 PM ISSUES FOR CONSUMERS
Ms Karen Carey, Consumer Advocate
3:00 PM BOOSTING POLICY RELEVANT RESEARCH USING LINKED ADMINISTRATIVE DATA
Prof Louisa Jorm, Foundation Professor of Population Health, University of Western Sydney

3:15 PM

Q&A PANEL DISCUSSION
3:30 PM AFTERNOON TEA

Session 4

Hypothetical -> A patient’s experience

Chair Prof Philip Davies, Professor of Health Systems and Policy, University of Queensland

4:00 PM PANEL
Mr Bruce Goodwin, Managing Director, Janssen
Ms Janne Graham AM, Healthcare Consumer Representative
Prof Christine Jenkins AM, Clinical Professor of Medicine, Sydney University; Senior Staff Specialist, Concord Hospital
Assoc Prof Malcolm Parker, Head of Medical Ethics, Law and Professional Practice, School of Medicine, University of Queensland
Mr Kos Sclavos, National President, The Pharmacy Guild of Australia
Assoc Prof Rosalie Viney, Deputy Director, Centre for Health Economics Research and Evaluation, University of Technology, Sydney
Dr Rob Walters, General Practitioner, Hobart, Tasmania
Prof Robyn Ward, Clinical Associate Dean, Prince of Wales Clinical School, University of NSW
Dr Nathan Pinskier, Program Clinical Lead NEHTA; Spokesperson on e-health for RACGP
5:30 PM Close day 1
7:00 PM CONFERENCE DINNER
The Great Hall, Australian Parliament House
-> People are the heart of the PBS

SPEAKERS

Mr Will Delaat, Chairman, Medicines Australia
Ms Jane Halton PSM, Secretary, Department of Health and Ageing

Day 2

Session 5

The relevance of the national medicines policy in the future

CHAIR Prof Andrew J. McLachlan, Chair, National Medicines Policy Committee; Professor of Pharmacy, University of Sydney

9:00 AM LINKAGES BETWEEN THE FOUR PILLARS OF THE NMP
Dr Lynn Weekes, Chief Executive Officer, NPS
9:15 AM LOOKING BACK AND LOOKING FORWARD: HOW DID WE GET HERE?
Prof Lloyd Sansom AO, Emeritus Professor, Division of Health Sciences, University of South Australia
9:30 AM THE IMPORTANCE OF DOCUMENTATION
Dr Ross Maxwell, Procedural Rural Doctor (Queensland), and Prescribing Expert on the National Medicines Policy
9:45 AM WHAT DEVELOPMENTS WILL IMPACT ON MEDICINES POLICY IN THE FUTURE
Dr Brendan Shaw, Chief Executive, Medicines Australia
10:00 AM Q&A PANEL DISCUSSION
10:30 AM MORNING TEA

Session 6

Facilitating access to medicines for special patient groups

CHAIR Dr John Primrose, Medical Adviser, Pharmaceutical Evaluation Branch, Department of Health and Ageing

11:00 AM FOCUS ON INDIGENOUS HEALTH
Prof Alan Cass, Professor, Sydney Medical School, University of Sydney, and Director of the Renal and Metabolic Division, George Institute, Sydney
11:15 AM ACCESS TO MEDICINES: POLICY AFFECTING ABORIGINAL PEOPLES
Dr Sophie Couzos, Public Health Medical Officer, Aboriginal community controlled health services and the National Aboriginal Community Controlled Health Organisation
11:30 AM FOCUS ON PAEDIATRIC HEALTH
Dr Sean Beggs, Paediatrician and Paediatric Clinical Pharmacologist, Royal Hobart Hospital
11:45 AM ACCESS TO MEDICINES FOR SPECIAL PATIENTS AND TARGET GROUPS
Ms Deborah Waterhouse, General Manager, GlaxoSmithKline Australia and New Zealand
12:00 PM Q&A PANEL DISCUSSION
12:30 PM LUNCH

Session 7

The influence of HTA in shaping future drug development

CHAIR Prof Kathryn A. Phillips, Professor of Health Economics and Health Services Research, University of California, San Francisco

1:30 PM INVESTMENT DECISIONS IN DRUG DEVELOPMENT
Dr Steve J. Romano, Senior Vice President, Pfizer, New York
2:00 PM INNOVATION DILEMMA: THE CASE OF ANTIMICROBIALS
Prof John Turnidge, Clinical Director of Microbiology and Infectious Diseases for SA Pathology, Women’s and Children’s Hospital, Adelaide
2:20 PM VALUING INNOVATION: HTA PRACTISE AND THE IMPACT FOR FUTURE MEDICINES
Mr Mendel Grobler, Director, Patient Access, Pfizer Australia

2:40 PM

Q&A PANEL DISCUSSION

Session 8

Wrap-up: Conference outcomes and key messages

CHAIR Mr Laurie Wilson, President, National Press Club

3:00 PM Ms Carol Bennett, Chief Executive Officer, Consumers Health Forum
3:10 PM Mr David Learmonth, Deputy Secretary, Department of Health and Ageing
3:20 PM Mr Will Delaat, Chairman, Medicines Australia
3:30 PM CONFERENCE CLOSING
Mr Laurie Wilson